Federico Goodsaid, Ph.D.
Vice President, Strategic Regulatory Intelligence
Vertex Pharmaceuticals Incorporated
Federico Goodsaid, Ph.D., is Vice President for Strategic Regulatory Intelligence at Vertex Pharmaceuticals. His work at Vertex is focused on early and effective interaction and collaborations on exploratory and product biomarkers with regulatory agencies. He was previously Associate Director for Operations in Genomics and Biomarker Qualification Coordinator at the Office of Clinical Pharmacology/Office of Translational Sciences/ Center for Drug Evaluation and Research/ U.S. FDA, working on the regulatory application and development of genomics and biomarkers at the FDA. His B.A. was in Biochemistry and Biophysics from the University of California at Berkeley and his Ph.D from Yale University in Molecular Biophysics and Biochemistry. He was a Postdoctoral Fellow at Cornell University and at Washington University in St. Louis. Before he joined the FDA, he was Senior Staff Scientist at Applied Biosystems and Lead for the Molecular Toxicology Group at the Schering-Plough Research Institute.